Ultragenyx Pharmaceutical(GB:0LIF)
$16.69+1.01 (+6.44%)
GB:0LIF
Ultragenyx Pharmaceutical hedge funds
$16.69
At close:+1.01 (+6.44%)
Ultragenyx Pharmaceutical (0LIF) Hedge Fund Trading Activity
0 Followers
Trend: ▼ Hedge Funds Decreased Holdings by 85.6K Shares Last Quarter
Hedge Fund Holdings in 0LIF
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Hedge Fund Activity
Activity
Star Ranking
 Ken Fisher | Fisher Asset Management LLC | Added | 18.21% | $4,570,008 | <0.01% | ||
 Felix Baker | Baker Bros Advisors LP | Not Changed | 0.00% | $63,771,916 | 0.37% | ||
 Frank Sands | Sands Capital Management LLC | Reduced | -7.54% | $80,171,652 | 0.24% | ||
 Louis Moore Bacon | Moore Capital Management LP | Reduced | -25.93% | $4,600,000 | 0.07% | ||
| Michael Rockefeller | Woodline Partners LP | Reduced | -37.13% | $3,951,515 | 0.02% | ||
 Richard Driehaus | Driehaus Capital Management LLC | Sold Out | -100.00% | $13,878,131 | 0.00% | ||
| Travis Knapp Anderson | Gilder Gagnon Howe & Co LLC. | Sold Out | -100.00% | $2,804,643 | 0.00% | ||
 Kenneth Tropin | Graham Capital Management, L.P. | Sold Out | -100.00% | $720,682 | 0.00% | ||
| Andrew Alkon | EntryPoint Capital, LLC | Sold Out | -100.00% | $263,718 | 0.00% | ||
| Andrew J.M. Spokes | Farallon Capital Management, L.L.C. | Sold Out | -100.00% | $161,000 | 0.00% |
FAQ
Which hedge funds hold Ultragenyx Pharmaceutical?
The hedge funds that hold the most shares in Ultragenyx Pharmaceutical are Frank Sands, Felix Baker and Louis Moore Bacon.
Are hedge funds buying or selling GB:0LIF?
In the last quarter hedge funds have Decreased their holdings in Ultragenyx Pharmaceutical by 85.6K shares.
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in Ultragenyx Pharmaceutical stock?
Warren Buffet currently does not own shares in Ultragenyx Pharmaceutical.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
